Use of liposomes as carriers for metalloporphyrins
US5010073A · kind A · utility
54Cited by
7References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 26, 1990 |
| Grant date | Apr 23, 1991 |
| Priority date | — |
| Expiry date | Feb 26, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical copositions comprising liposomal metalloporphyrins are provided for parenteral administration to mammals, including humans. These liposomal metalloporphyrins selectively target the spleen and markedly inhibit the heme oxygenase activity therein. A method is also provided for intravenous administration of these compositions to mammals to selectively target the spleen.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.